| Patent Number |
Title Of Patent |
Date Issued |
| 7128930 |
Compositions and methods for treating sexual dysfunction |
October 31, 2006 |
| Methods for treating sexual dysfunction are disclosed. The methods generally comprise the administration of an NO donor and an antioxidant; the active ingredients can be administered topically to the genitals of the patient. The methods allow for localized NO delivery through topical |
| 6962927 |
Method for potentiating primary drugs in treating multidrug resistant disease |
November 8, 2005 |
| The specification discloses a method for enhancing the inhibiting action of drugs against multidrug resistant cells, apparently by reversing or inhibiting the glycoprotein "pumps" associated with such cells. |
| 6911454 |
Method for potentiating primary drugs in treating multidrug resistant disease |
June 28, 2005 |
| The specification discloses a method for enhancing the inhibiting action of drugs against multidrug resistant cells, apparently by reversing or inhibiting the glycoprotein "pumps" associated with such cells. |
| 6544726 |
KVD solution for transplantable organs |
April 8, 2003 |
| The present invention is directed to a composition and method of preserving organs comprising exposing said organs to a preservation solution that includes at least an inhibitor or quencher of peroxynitrite. In its most easily formulated embodiment the present invention is a modified Wis |
| 6528519 |
Use of tetrandrine and its derivatives to treat malaria |
March 4, 2003 |
| The specification discloses the treatment of malaria through the use of tetrandrine and its derivatives. |
| 6514955 |
Multi-faceted method to repress reproduction of latent viruses in humans and animals |
February 4, 2003 |
| Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use |
| 6124315 |
Method for potentiating primary drugs in treating multidrug resistant disease |
September 26, 2000 |
| The specification discloses a method for enhancing the inhibiting action of drugs against multidrug resistant cells, apparently by reversing or inhibiting the glycoprotein "pumps" associated with such cells. |
| 5846961 |
Multi-faceted method to repress reproduction of latent viruses in humans and animals |
December 8, 1998 |
| Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use |
| 5686436 |
Multi-faceted method to repress reproduction of latent viruses in humans and animals |
November 11, 1997 |
| Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutical compositions and kits for use |
| 5332747 |
Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells |
July 26, 1994 |
| The specification discloses a method for enhancing the inhibiting action of drugs against multidrug resistant cells, representing various parasitic diseases, apparently by reversing the glycoprotein "pumps" associated with such cells. |
| 5096733 |
Prevention of the acute cytotoxicity associated with silica containing minerals |
March 17, 1992 |
| Cytotoxic effects associated with ground fractured silica-containing minerals and silicates, including asbestos, are prevented by coating the silica-containing minerals and silicates with an aqueous solution containing an aqueously compatible silane coupling agent so that a monomolec |
| 5025020 |
Use of tetrandrine and its derivatives to treat malaria |
June 18, 1991 |
| The specification discloses the treatment of malaria through the use of tetrandrine and its derivatives. |
